HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
427.71
-1.33 (-0.31%)
Sep 18, 2026, 4:00 PM EDT - Market closed
HCA Healthcare Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $452.67. The average 1-year stock price forecast is 5.84% higher than the current stock price, while the lowest is $380 (-11.15%) and the highest is $579 (+35.37%).
Price Target: $452.67 (+5.84%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 13 | 13 | 13 | 13 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 9 | 9 | 9 | 10 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 25 | 25 | 25 | 25 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Jefferies | Jefferies | Buy Maintains $450 | Buy | Maintains | $450 | +5.21% | Sep 17, 2026 |
| Bernstein | Bernstein | Hold Maintains $426 | Hold | Maintains | $426 | -0.40% | Sep 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $435 | Buy | Maintains | $435 | +1.70% | Sep 8, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $425 | Hold | Maintains | $425 | -0.63% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
78.51B
from 75.60B
Increased by 3.85%
Revenue Next Year
81.66B
from 78.51B
Increased by 4.01%
EPS This Year
29.49
from 28.21
Increased by 4.54%
EPS Next Year
32.02
from 29.49
Increased by 8.58%
EPS and Forward PE are based on non-GAAP adjusted numbers.